Found 10 matching trials
A Study to Evaluate Safety, Tolerability, and Efficacy of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) Who Have Completed Study 4658-102 (NCT03218995) PHASE2 The purpose of this extension study is to evaluate the ongoing safety and t...
Show More Learn More & Join Trial
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy PHASE2 This is an open-label study to assess the safety, tolerability, efficacy an...
Show More Location
Neuromuscular Research Center of Arizona
Learn More & Join Trial
A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON) PHASE3 Part 1 (dose escalation) will evaluate the safety and tolerability of 2 dos...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
A 48-Week, Open Label, Study to Evaluate the Efficacy and Safety of AMONDYS 45, EXONDYS 51, VYONDYS 53 in Subjects With DuchenneMuscular Dystrophy Carrying Eligible DMD Duplications. PHASE2 This is an 48-week open-label study to determine the efficacy and safety of...
Show More Location
Nationwide Children's Hospital
Learn More & Join Trial
Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy PHASE2 The primary objective of this study is to assess the ongoing efficacy, safe...
Show More Location
Miller Children's Hospital
Learn More & Join Trial
Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy PHASE2 The primary objective of this study is to explore safety and tolerability o...
Show More Location
Ronald Reagan UCLA Medical Center
Learn More & Join Trial
Study of Eteplirsen in DMD Patients PHASE3 The main objective of this study is to provide evidence of efficacy of etep...
Show More Location
Neuromuscular Research Center
Learn More & Join Trial
Study of Eteplirsen in Young Participants With Duchenne Muscular Dystrophy (DMD) Amenable to Exon 51 Skipping PHASE2 This is a multicenter, open-label, dose-escalation study to evaluate the sa...
Show More Location
Universitair ziekenhuis Gent
Learn More & Join Trial
Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients PHASE1 The specific aim of this Phase I/II study is to assess the safety of intrav...
Show More Location
Great Ormond Street Hospital
Learn More & Join Trial
A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice N/A This is a phase 4, multicenter, prospective, observational study designed t...
Show More Status
Enrolling By Invitation
Location
Arkansas Children's Hospital Research Institute
Learn More & Join Trial